Joustra Wouter
SEC insider (Form 3/4/5 filer). CIK 0001897813. Director at enGene Therapeutics Inc. (ENGN) and 1 other issuer. 4 reported Form 4/5 transactions since Sep 2024; latest on Jun 16, 2026. Located in BOSTON, MA.
Companies Joustra Wouter has filed insider reports for
- enGene Therapeutics Inc. (ENGN): Director
- Vor Biopharma Inc. (VOR): Director
Joustra Wouter
CIK: 0001897813
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jun 16, 2026ENGN
enGene Therapeutics Inc.
AwardDirectStock Option (Right to Buy)
31K shares- - Jun 11, 2026VOR
Vor Biopharma Inc.
AwardDirectStock option (right to buy)
57.2K shares- - Dec 18, 2025VOR
Vor Biopharma Inc.
AwardDirectStock Option (Right to Buy)
3K shares- - Jun 16, 2025ENGN
enGene Holdings Inc.
AwardDirectStock Option (Right to Buy)
22.5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 16, 2026 |  ENGN enGene Therapeutics Inc. | Award Stock Option (Right to Buy) | 31,000 | - | - | Direct |
| Jun 11, 2026 |  VOR Vor Biopharma Inc. | Award Stock option (right to buy) | 57,162 | - | - | Direct |
| Dec 18, 2025 | VOR Vor Biopharma Inc. | Award Stock Option (Right to Buy) | 3,000 | - | - | Direct |
| Jun 16, 2025 | ENGN enGene Holdings Inc. | Award Stock Option (Right to Buy) | 22,500 | - | - | Direct |
1-4 of 4 transactions